Industry Discovery & Development Partnership (IDDP) Program
Breakthrough T1D's IDDP Program funds for-profit research on T1D therapies and devices, focusing on projects with strong commercialization potential and collaborative, milestone-driven development.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs and applications accepted year-round)
Funding Amounts: Award size and duration are flexible, determined on a case-by-case basis; matching funds from the company are required.
Summary: Supports for-profit organizations conducting research and development of therapies or devices for type 1 diabetes, with a focus on projects aligned to Breakthrough T1D priorities and commercialization potential.
Key Information: Applicants must contact Breakthrough T1D before submitting a Letter of Intent; matching funds and a collaborative approach are required.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D is designed to accelerate the discovery, development, and commercialization of therapeutics and devices for type 1 diabetes (T1D). The program specifically supports for-profit entities—such as biotechnology, pharmaceutical, and device companies—whose research projects closely align with Breakthrough T1D’s research strategy and priorities. The IDDP fosters collaboration between industry and Breakthrough T1D, leveraging the commercial sector’s strengths in product development and Breakthrough T1D’s expertise in T1D research and advocacy.
Projects funded under this mechanism should have a clear path toward commercialization and demonstrate significant potential impact for the T1D community. The program emphasizes milestone-driven research, joint oversight, and a requirement for applicants to commit matching resources.
